title: Progress in the development of small molecule therapeutics targeting Th17 cell function for the treatment of immune-inflammatory diseases.
authors.affiliation: Karus Therapeutics Ltd., 2 Venture Road, Southampton Science Park, Southampton, SO16 7NP, UK.
authors.forename: Stephen
authors.initials: S
authors.lastname: Shuttleworth
authors.forename: Paul
authors.initials: P
authors.lastname: Townsend
authors.forename: Franck
authors.initials: F
authors.lastname: Silva
authors.forename: Alexander
authors.initials: A
authors.lastname: Cecil
authors.forename: Thomas
authors.initials: T
authors.lastname: Hill
authors.forename: Cyrille
authors.initials: C
authors.lastname: Tomassi
authors.forename: Helen
authors.initials: H
authors.lastname: Rogers
authors.forename: Rebecca
authors.initials: R
authors.lastname: Harrison
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D055808:Drug Discovery / Q000379:methods*; D006801:Humans; D007154:Immune System Diseases / Q000188:drug therapy* / Q000276:immunology; D007249:Inflammation / Q000188:drug therapy* / Q000276:immunology; D054852:Small Molecule Libraries / Q000737:chemistry* / Q000494:pharmacology / Q000627:therapeutic use*; D058504:Th17 Cells / Q000187:drug effects* / Q000276:immunology
chemical_list: D000893:Anti-Inflammatory Agents; D054852:Small Molecule Libraries